摘要
目的:探讨阿奇霉素不同疗程对小儿肺炎支原体肺炎的临床治疗效果。方法:根据阿奇霉素不同疗程将2015年8月~2017年1月期间于某院就诊的140例肺炎支原体感染患儿分为两组,对照组使用阿奇霉素的治疗疗程≤5d,观察组使用阿奇霉素的治疗疗程为7d,比较两组患儿的住院时间、症状消失时间、治疗有效率及不良反应发生情况。结果:观察组住院时间、肺部啰音、X线片阴影及咳嗽消失时间均明显短于对照组(P<0.05);观察组治疗有效率为91.4%(64/70),明显高于对照组治疗有效率75.7%(53/70)(P<0.05);两组患儿的不良反应发生率比较无差异(P>0.05)。结论:在小儿肺炎支原体肺炎的临床治疗中,使用阿奇霉素7d疗程治疗效果较为理想,无严重不良反应,安全性可以保证,且患儿临床症状改善明显,值得推广。
Objective： To investigate the clinical effect of azithromycin in the treatment of mycoplasma pneumonia in children. Methods： According to the different treatment of azithromycin 140 cases of mycoplasma pneumonia from August 2015 to January 2017 in a hospital were divided into two groups. The period of treatment with azithromycin was less than or equal to 5D for control group and 7D for observation group. Two groups were compared with the length of time, the symptoms disappeared time, the effective rate of the treatment and the incidence of adverse reactions. Results. In the observation group, hospitalization time, pulmonary tales, X-ray shadow and cough disappearance time were significantly shorter than the control group （P〈0.05） ; in the observation group, the effective rate of treatment was 91.4% （64/70）, significantly high- er than the control group with a cure rate of 75.7% （53/70） （P〈0.05） ; the adverse reactions of two groups of children had no difference （P〉0.05）. Conclusion. In the clinical treatment of children with mycoplasma pneumonia, the curative effect of 7D treatment using azithromycin is ideal. There is no serious adverse reaction, safety can be guaranteed, and the clinical symptoms improved significantly, worthy of promotion.
出处
《数理医药学杂志》
2017年第12期1845-1846,共2页
Journal of Mathematical Medicine
